Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Mar;35(3):614–619. doi: 10.1128/jcm.35.3.614-619.1997

Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.

D A Henry 1, M E Campbell 1, J J LiPuma 1, D P Speert 1
PMCID: PMC229637  PMID: 9041399

Abstract

We evaluated 819 isolates referred to us as "Burkholderia cepacia" from cystic fibrosis (CF) clinics and research laboratories from five countries; 28 (3.4%) were not B. cepacia. A further 12 (1.5%) organisms appeared to be other Burkholderia species, but identification could not be confirmed by conventional means. The most prevalently misidentified organisms were Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and Comamonas acidovorans. Many of these organisms grew on oxidation-fermentation polymyxin-bacitracin-lactose (OFPBL) and Pseudomonas cepacia agars, selective media currently used for B. cepacia isolation. We developed a new medium, B. cepacia selective agar (BCSA), which is more enriched for the growth of B. cepacia yet which is more selective against other organisms than currently available selective agars. A total of 190 of 191 (99.5%) isolates of B. cepacia from patients with CF grew on BCSA without vancomycin, whereas 100% grew on OFPBL agar and 179 (94.2%) grew on P. cepacia agar. Of 189 other gram-negative and gram-positive organisms tested, 10 (5.3%) grew on BCSA without vancomycin. The addition of vancomycin to BCSA lowered the false positivity rate to 3.7% without further inhibition of B. cepacia. The false positivity rates for OFPBL and P. cepacia agars were 19.6 and 13.8%, respectively. Isolates of B. cepacia from CF patients grew most quickly on BCSA, with 201 of 205 (98.0%) being readily visible within 24 h, whereas 182 (88.8%) grew on OFPBL agar and 162 (79.0%) grew on P. cepacia agar within 24 h. We propose that the use of BCSA will allow investigators to overcome many of the difficulties associated with the identification of B. cepacia and should be considered for use as a primary isolation agar for specimens from patients with CF.

Full Text

The Full Text of this article is available as a PDF (93.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burdge D. R., Noble M. A., Campbell M. E., Krell V. L., Speert D. P. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clin Infect Dis. 1995 Feb;20(2):445–448. doi: 10.1093/clinids/20.2.445. [DOI] [PubMed] [Google Scholar]
  2. Campbell P. W., 3rd, Phillips J. A., 3rd, Heidecker G. J., Krishnamani M. R., Zahorchak R., Stull T. L. Detection of Pseudomonas (Burkholderia) cepacia using PCR. Pediatr Pulmonol. 1995 Jul;20(1):44–49. doi: 10.1002/ppul.1950200109. [DOI] [PubMed] [Google Scholar]
  3. Christenson J. C., Welch D. F., Mukwaya G., Muszynski M. J., Weaver R. E., Brenner D. J. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol. 1989 Feb;27(2):270–273. doi: 10.1128/jcm.27.2.270-273.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clark W. A. A simplified Leifson flagella stain. J Clin Microbiol. 1976 Jun;3(6):632–634. doi: 10.1128/jcm.3.6.632-634.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gilligan P. H., Gage P. A., Bradshaw L. M., Schidlow D. V., DeCicco B. T. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 1985 Jul;22(1):5–8. doi: 10.1128/jcm.22.1.5-8.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Govan J. R., Brown P. H., Maddison J., Doherty C. J., Nelson J. W., Dodd M., Greening A. P., Webb A. K. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993 Jul 3;342(8862):15–19. doi: 10.1016/0140-6736(93)91881-l. [DOI] [PubMed] [Google Scholar]
  7. HUGH R., LEIFSON E. The taxonomic significance of fermentative versus oxidative metabolism of carbohydrates by various gram negative bacteria. J Bacteriol. 1953 Jul;66(1):24–26. doi: 10.1128/jb.66.1.24-26.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kiska D. L., Kerr A., Jones M. C., Caracciolo J. A., Eskridge B., Jordan M., Miller S., Hughes D., King N., Gilligan P. H. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol. 1996 Apr;34(4):886–891. doi: 10.1128/jcm.34.4.886-891.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lipuma J. J., Marks-Austin K. A., Holsclaw D. S., Jr, Winnie G. B., Gilligan P. H., Stull T. L. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J. 1994 Aug;13(8):716–719. doi: 10.1097/00006454-199408000-00007. [DOI] [PubMed] [Google Scholar]
  10. Mahenthiralingam E., Campbell M. E., Henry D. A., Speert D. P. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol. 1996 Dec;34(12):2914–2920. doi: 10.1128/jcm.34.12.2914-2920.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stull T. L., LiPuma J. J., Edlind T. D. A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. J Infect Dis. 1988 Feb;157(2):280–286. doi: 10.1093/infdis/157.2.280. [DOI] [PubMed] [Google Scholar]
  12. Tablan O. C., Carson L. A., Cusick L. B., Bland L. A., Martone W. J., Jarvis W. R. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol. 1987 Mar;25(3):485–487. doi: 10.1128/jcm.25.3.485-487.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Welch D. F., Muszynski M. J., Pai C. H., Marcon M. J., Hribar M. M., Gilligan P. H., Matsen J. M., Ahlin P. A., Hilman B. C., Chartrand S. A. Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol. 1987 Sep;25(9):1730–1734. doi: 10.1128/jcm.25.9.1730-1734.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES